VP-102
VP-CW-301
Phase 3 other active
Quick answer
VP-102 for Common Warts is a Phase 3 program (other) at Verrica Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Verrica Pharmaceuticals
- Indication
- Common Warts
- Phase
- Phase 3
- Modality
- other
- Status
- active